XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies WESTBURY, N.Y., Sept. 12, ...

Arsenal Capital Partners and Linden Capital have recapitalized BioIVT, a Westbury, New York-based provider of biological specimens and value-added services for the academic research, pharmaceutical, ...

WESTBURY, N.Y.--(BUSINESS WIRE)--BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced a complimentary neuroscience symposium in ...

BioIVT, a leading provider of research models and services for drug and diagnostic development, is hosting a webinar in which researchers will discuss how they used a sandwich-cultured human ...

WESTBURY, N.Y.--(BUSINESS WIRE)--BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced it will host “Elevating Drug Development with ...

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it will host a symposium entitled “Innovative Models for ADME-Tox ...

WESTBURY, N.Y., Aug. 1, 2022 /PRNewswire/ -- BioIVT, LLC ("BioIVT"), a leading global provider of biospecimens, cell and gene therapy related products, and research models and services for drug ...

Based in Chicago, Linden Capital invests in middle-market healthcare and life science companies Linden Capital was founded in 2004 BioIVT, a portfolio company of Linden Capital, has acquired ZenBio, a ...

WESTBURY, N.Y., July 18, 2023 /PRNewswire/ -- BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced today that it has acquired ...

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced an exclusive commercial agreement with Handok Biotech Co. LTD., which will ...